Coronavirus Impact: What Will Happen to Canada’s Marijuana Stocks?

Marijuana stocks such as Canopy Growth (TSX:WEED)(NYSE:CGC) have plenty of reasons to bounce back stronger from this economic crisis.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Much of the country is on lockdown, as authorities tackle the coronavirus outbreak. Investors are rightfully concerned about the impact on the Canadian economy and investments. A nearly 100% decline in economic activity is unprecedented, and there’s no easy way to measure the long-term consequences. Particularly concerning are the country’s legal marijuana stocks. 

The cannabis sector was already struggling with supply-chain and debt issues. Now, the sector has collectively lost billions in value as the stock market crashed. Investors have dumped unprofitable cannabis stocks as the global market becomes more risk averse.  

However, savvy investors willing to make a contrarian bet could find some opportunities in this market crash. Here’s how. 

Marijuana sales

Ontario premier Doug Ford announced that all “non-essential” businesses will be required to shut down from midnight Tuesday for a period of 14 days. That means plenty of small restaurants, salons, and gyms will have to remain shut, which could create cash flow issues. 

However, the legislature seems to have made an exception for pot shops. Legal cannabis stores are not classified as “non-essential” according to BNN Bloomberg.  This is also true in Quebec, another province that has shut down recently. In fact, legal marijuana sales have spiked in recent weeks. It seems social distancing leaves people with more time on their hands and few other alternatives for recreation. 

A spike in sales while the rest of the economy shuts down could be a boon for the struggling marijuana sector. However, not all companies are well positioned to survive this ongoing crisis unscathed. 

Debt concerns

Corporate debt has always been a concern for the cannabis sector. Tilray, for example, reported $1.64 in debt for every dollar in equity in its latest filing. 

As capital markets become more volatile, investors tend to dump risky corporate debt, making it more expensive for companies to borrow. This spike in debt interest rates, and lack of funding from investors could create serious cash flow issues for companies with too much debt and no profits.   

Top marijuana stocks

The top marijuana stocks seem much better placed to survive this crisis. Canopy Growth, for example, has a debt-to-equity ratio of just 12%. The company is also backed by one of the largest alcohol companies on the planet and has roughly $2.3 billion in cash and cash equivalents on its books. 

If Canopy’s Tokyo Smoke stores remain open across Canada and sales spike while smaller rivals face cash flow issues, the company has a chance to finally consolidate the market. Seizing more market share now will allow larger companies like Canopy to emerge as the dominant players in this fascinating sector. 

Foolish takeaway

The stock market crash reflects the growing concerns about our economy and health. As the COVID-19 pandemic accelerates, the provincial and federal governments could be compelled to take tougher measures. Social distancing and extensive shutdowns are likely to have a long-term impact on the local economy. 

However, well-funded cannabis companies could survive this downturn and seize more market share. Contrarian investors seeking opportunities should probably add the top marijuana stocks to their watch lists for 2020. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »